hVIVO plc (HVO) To Go Ex-Dividend on April 18th

hVIVO plc (LON:HVO) declared a dividend on Tuesday, April 9th, Upcoming.Co.Uk reports. Investors of record on Thursday, April 18th will be paid a dividend of GBX 0.20 ($0.00) per share on Monday, May 20th. This represents a yield of 0.68%. The ex-dividend date of this dividend is Thursday, April 18th. The official announcement can be viewed at this link.

hVIVO Trading Down 3.6 %

Shares of HVO stock opened at GBX 27.24 ($0.34) on Tuesday. hVIVO has a 12-month low of GBX 14 ($0.17) and a 12-month high of GBX 32 ($0.40). The company has a market capitalization of £185.36 million, a P/E ratio of -1.00 and a beta of 0.99. The firm has a 50-day moving average price of GBX 28.10 and a 200 day moving average price of GBX 24.15. The company has a quick ratio of 1.16, a current ratio of 1.46 and a debt-to-equity ratio of 9.83.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.